Patients and Methods

Patients
Four patients were diagnosed with LS at dermatology and/or genetic counseling clinics at National Cheng Kung University Hospital, Tainan, Taiwan. For diagnosis of LS, the presence of lentigines was required, in combination with at least one 
Screening of PTPN11
Point mutations were identified by sequence analysis of amplified DNA that contained the PTPN11 gene.
Results
Clinical presentation
There were one female and three male patients. All cases were identified initially by ML. Other clinical presentations are summarized in the most common heart defect in LS, was noted in three cases. Pulmonary stenosis (PS) was noted in case 3. None of the patients had any conduction abnormality revealed by ECG. Development and growth were the two major issues for patients with LS. Three patients had short stature (height below the 3rd centile). Twin B had mild mental retardation. Case 4 suffered from moderate hearing impairment.
Mutation analysis
The point mutation T468M that changes amino acid 468 from threonine to methionine was identified in the twins, case 3 and her mother. In case 4, another point mutation, G464A, changed amino acid 464 from glycine to alanine.
Discussion
Lentigines
The phenotype of ML is the most distinct feature of LS. A French multicenter study pooled 30 cases, among which 28 had lentiginosis. 4 Sarkozy et al reported 30 cases and ML were also present in most cases (86%). 5 The lesions presented as flat, black-brown macules all over the body, but mostly on the face, neck and upper part of the trunk. They develop classically during childhood, increasing in number and darkening in color with age. 8 In the twins presented here, their skin lesion did not appear at birth. The diagnosis was not made until the age of 8 years when lentigines appeared. In the literature review, the mean age at report was also around infancy and during childhood.
4,5
Electrocardiographic conduction and cardiac structural abnormalities
Electrocardiographic conduction abnormalities and PS were the two major criteria proposed by Gorlin et al. 3 HCM was more common than PS. Cardiac structural and conduction abnormalities are the major determinants of mortality and morbidity in LS. Sudden cardiac death has previously been reported in patients with LS. 10, 11 The two previously reported patients both had HCM and conduction abnormalities. Three of our four cases had HCM. Case 3 had severe valvular PS. Conduction abnormalities in LS have been reported to occur gradually and progressively. 9 Fortunately, no conduction abnormality was noted during the regular follow-up of our cases.
Ocular hypertelorism
Reviewing the literature, the clinical presentation of hypertelorism is quite common, and this sign was also noted in three of our patients.
Genital abnormalities
Genital abnormalities include hypospadias and cryptorchidism. 12 In 1984, Colomb and Morel 13 reviewed 38 cases and found that 29% had abnormal genitalia (males). No genital abnormality was noted in our cases.
Deafness (sensorineural)
Sensorineural hearing loss has been documented in about 25% of patients with LS. 2, 12 Hearing impairment can be detected early in the neonatal stage by auditory brainstem response audiometry (ABR). Our twins were diagnosed with hearing impairment at birth by ABR. During follow-up, both of their hearing was normal, as confirmed by pure-tone testing. Case 4 had bilateral moderate hearing impairment (right ear: 102 db; left ear: 87 db), and is wearing a hearing aid at present.
Growth and mental retardation
Colomb and Morel reported that 42% of LS had short stature. 12, 13 In our patients, three had short stature (height below the 3rd centile). The height of case 4 was around the 10th centile. Colomb and Morel reported mental retardation in 35% of cases.
12,13 Sarkozy et al reviewed 30 cases and eight had mental retardation. 5 In our cases, according to the Wechsler Primary and Preschool Scale of Intelligence-Revised (WPPSI-R), only twin B had mental retardation during follow-up.
Other clinical manifestations
The presence of tongue protrusion and hepatosplenomegaly in our twins has not been mentioned previously. The etiology of hepatosplenomegaly was investigated. No evidence of congenital infection was found. Liver biopsy showed no evidence of glycogen storage or other hepatic disease.
The tongue protrusion subsided gradually with age. However, the hepatosplenomegaly persisted during follow-up.
Mutations in PTPN11 gene
The PTPN11 gene encodes the protein tyrosine phosphatase SHP-2, which contains two Src homology 2 (SH2) domains. SHP-2 is a critical component of signal transduction for several growth factor-, hormone-, and cytokine-signaling pathways that control developmental processes and hematopoiesis, as well as energy balance and metabolism. 14 With the crucial role of SHP-2 in development, germline mutations in PTPN11 have been identified in cases of LS, Noonan syndrome and hematologic malignancies, including juvenile myelomonocytic leukemia, myelodysplastic syndromes, acute myeloid leukemia, 15 and acute lymphoblastic leukemia. 14 In 2002, two teams first reported that patients with LS also had mutations in PTPN11. 6, 7 The mutations account for up to 90% of cases. 4, 14 Among all mutations, T468M and Y279C account for the majority of cases. No specific genotypephenotype correlation has been found. Further study is needed in Asian patients to identify if there are racial differences in the point mutations.
The point mutations T468M 4, 6, 14 and G464A 5, 14 that were found in our cases have been reported in the literature. The mother of case 3 also had the same mutation as her daughter. In the other three cases, according to family history, we believe that the mutations occurred de novo.
Conclusion
As a rare disease, LS can be identified by the typical feature of ML. For the wide spectrum of the syndrome, all patients should receive comprehensive examination, including echocardiography and ECG by cardiologists. A hearing test is also warranted. For the high prevalence of short stature and mental retardation, all patients need close follow-up by pediatricians and might require early intervention. At present, molecular analysis enables us to confirm the diagnosis and make genetic counseling and prenatal diagnosis more accurate.
